Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | CA7 | P43166 | 2/20 | 0.61 |
| ▸ | CA9 | Q16790 | 2/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.56 |
| ▸ | MIF | P14174 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ALB | P02768 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 2/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9627416 | 0.98 | CA12 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11015067 | 0.84 | CES2 (0.48) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7607212 | 0.84 | RARB (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3816558 | 0.82 | CES2 (0.46) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1264408 | 0.82 | CA1 (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9939389 | 0.82 | ESR1 (0.62) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3810726 | 0.80 | CES2 (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29799863 | 0.80 | MAOB (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL310878 | 0.80 | MAOB (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9627405 | 0.80 | ALDH1A1 (0.54) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 683 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250297057-A1 | LIQUID CRYSTALLINE POLYESTER, MOLDED ARTICLE, AND ELECTRIC/ELECTRONIC COMPONENT | ENEOS MATERIALS CORPORATION (JP) | 2025-09-25 | — | — | US | claimed |
| CN-119256038-A | Liquid crystal polyester resin, molded article, and electric/electronic component | 株式会社引能仕材料 | 2025-01-03 | — | — | CN | claimed |
| CN-118420919-A | Metal organic framework material with trivalent boron blocked Lewis acid-base pair with fixed structures at two ends, preparation method and application thereof | 武汉大学 | 2024-08-02 | — | — | CN | claimed |
| WO-2023228573-A1 | LIQUID-CRYSTAL POLYESTER RESIN, MOLDED ARTICLE, AND ELECTRICAL/ELECTRONIC COMPONENT | ＥＮＥＯＳ株式会社 | 2023-11-30 | — | — | WO | claimed |
| CN-116178685-A | LCP material with high clearing point and preparation method thereof | 宁夏清研高分子新材料有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-115073074-A | Environment-friendly solid waste recycled concrete and preparation method thereof | 平泉市岩石建筑材料有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-113816940-A | Nicotine salts, co-crystals and salt co-crystal complexes | R.J.雷诺兹烟草公司 | 2021-12-21 | — | — | CN | claimed |
| CN-113754634-A | Nicotine salts, co-crystals and salt co-crystal complexes | R.J.雷诺兹烟草公司 | 2021-12-07 | — | — | CN | claimed |
| EP-1089988-B1 | FLUOROPHENYL RESIN COMPOUNDS | AVENTIS PHARMA INC (US) | 2009-08-12 | — | — | EP | claimed |
| US-6639023-B1 | Such as 4-hydroxy, sulfonic acid or sulfonyl chloride-2,3,5,6-tetrafluorobenzamidomethyl-polystyrene resin; solid phase synthesis | AVENTIS PHARMACEUTICALS INC. | 2003-10-28 | — | — | US | claimed |
| CN-1307553-A | Solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds | AVANTIES MEDICINE PRODUCT CO (US) | 2001-08-08 | — | — | CN | claimed |
| JP-11310551-A | — | — | None | — | — | JP | disclosed |
| JP-5186402-A | — | — | None | — | — | JP | disclosed |
| JP-11279124-A | — | — | None | — | — | JP | disclosed |
| US-20260107969-A1 | AEROSOL GENERATING MATERIAL COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| EP-0251335-A2 | Halogenen-substituted phenyl benzyl ether derivatives, liquid crystal compositions containing them and optical switching element | Chisso Corporation (JP) | 1988-01-07 | — | — | EP | disclosed |
| EP-0227717-A1 | NITROGEN-CONTAINING HETEROCYCLIC ESTERS. | MERCK PATENT GMBH (DE) | 1987-07-08 | — | — | EP | disclosed |
| WO-1986007055-A1 | NITROGEN-CONTAINING HETEROCYCLIC ESTERS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1986-12-04 | — | — | WO | disclosed |
| EP-0197677-A2 | Halogen-containing, optically active liquid crystal compound and liquid crystal composition containing same | Chisso Corporation (JP) | 1986-10-15 | — | — | EP | disclosed |
| EP-0188222-A2 | Novel liquid cristalline compounds having substituents | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1986-07-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260107969-A1 | AEROSOL GENERATING MATERIAL COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | CHRM1, CHRM3, ATRIP | CA12 3691/4885CA1 4118/4885CA2 2237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.